{
  "success": true,
  "pagesUsed": [],
  "modelUsed": "unknown",
  "amendmentdetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA), Table 1",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added footnote text regarding procedures specific to screening sites in the US."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 4.2 - Scientific Rationale for Study Design",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Updated the expected duration for the inhibitory effect of zinc on intestinal copper absorption."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 8 - Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Introduced a new operational model for US sites to perform only screening procedures."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3.1",
        "reasonText": "To facilitate participant recruitment across different regions of the US and lessen inconvenience for participants without compromising study quality.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3.1",
        "reasonText": "To align the number of days for zinc discontinuation with mentions elsewhere in the protocol.",
        "category": "Scientific",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_3",
        "amendmentId": "amend_3.1",
        "reasonText": "Clarification of study procedures occurring across different sites in the US.",
        "category": "Administrative",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3.1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Procedures specific to screening sites (only in the US) detailed in Section 8",
        "summary": "Added footnote to SoA Table 1 regarding US screening sites."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3.1",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc",
        "afterText": "inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc",
        "summary": "Changed zinc discontinuation effect period from 30 days to 21 days."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3.1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Addition of text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "Added provision for US-specific screening-only sites."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 3,
      "changeCount": 3
    }
  }
}